CCL2 and colorectal cancer: Furthermore, another study found that recombinant heparanase added to colorectal cancer cell lines could increase mRNA expression and release of monocyte chemoattractant protein-1 (MCP-1) (63), supporting the notion that heparanase may help to generate a chemokine gradient to recruit macrophages to sites of inflammation.